522: Short-term outcomes of severe early-onset uteroplacental fetal growth restriction managed in a tertiary centre

Therapies to treat fetal growth restriction (FGR) are emerging, focused on the most severely affected early-onset cases in which risk:benefit may be most balanced. Published series of severe early-onset FGR generally begin at birth rather than diagnosis, making assessment/prognostication of potential therapeutic efficacy in trials challenging. Our aim was to determine the natural history of severe early-onset FGR secondary to uteroplacental...